Nantes is a leader in biotechnology health and research. In 2005, Atlanpole Biothérapies obtained the status of « competitiveness cluster » to further strengthen local capabilities. The reputation of Nantes research, combined with the presence of major structuring facilities and innovative SMEs are all part of what makes Nantes an attractive city in the health sector.
ON THE CUTTING EDGE IN BIOTHERAPIES
Biotherapeutics are a priority for economic development in Nantes Saint-Nazaire. Atlanpole Biotherapies, an interregional competitiveness cluster, brings together over 200 members working in immunotherapy, regenerative medicine and innovative technologies in biotherapy and radiopharmaceuticals. Some are European or world leaders in their respective fields, like Eurofins (bio-analysis) Valneva (vaccines against emerging infectious diseases) and Biomérieux. The research focuses on three main themes: immunotherapy, radiopharmaceuticals and regenerative medicine.West Biotherapy is the one stop shop for cell and gene therapy projects in Nantes. Unique in France, it covers the entire value chain. Covering 1,200 m2 and bringing together 120 experts, it supports leaders in biotherapies such as Horama, an expert in gene therapy treatments, who has chosen to settle in Nantes.
The "Nantes Biotech" business hotel, adjoining the new Health Research Institute (IRS 2020), welcomes biotechnology start-ups next door to the future CHU
AT THE CUTTING EDGE OF DIGITAL HEALTH
Connected health, telemedicine, digital stimulation, data, artificial intelligence… in Nantes and Saint-Nazaire, researchers and startups are inventing the e-health solutions of tomorrow for carers and patients. Leader in teleconsultation, Doctolib was sur of its decision hen it set up its 2nd national branch in Nantes in 2020. Likewise, around ten innovative start-ups in the field of e-health, well-being and better living, at the crossroads digital technology, have taken up residence in the Creative Care Factory, in the heart of Nantes’ Creative District.THE "HOSPITAL OF THE FUTURE" IN NANTES IN 2026
With its 12,500 employees (including 1,200 doctors), the Nantes University Hospital is piloting numerous health research projects. The establishment is home to the Institute for Urology-Nephrology Transplantation (Itun), one of the leading European centers for kidney and pancreas transplants. Some 2,000 clinical trials are underway at Nantes University Hospital, France's leading center for early phase clinical trials in hematology and France's leading center for nuclear oncology. The 2nd cancer center in France, the Institut de Cancérologie de l'Ouest (ICO), based in St-Herblain, will also be completely renovated by 2023.
The relocation of the future University Hospital on the Ile de Nantes creates new opportunities for the biotechnology and health sector. More than simply a new hospital, a new health district will emerge, with 36,000m2 for the university faculty of health, 7,000 students and numerous research institutes. A development project that aims to position Nantes at the forefront of the future in hospital care and to attract the best researchers in the world.
